SAN RAMON, Calif., December 11, 2023—To further enable eye care professionals to fit more patients in contact lenses, CooperVision has expanded support for its full range of Biofinity® sphere contact lenses, including Biofinity® XR. With this enhancement, Biofinity® and Biofinity® XR together offer sphere powers from +15.00D to -20.00D and are now available at an equal price and with equal patient rebates across the range.
With Biofinity® contact lenses, eye care professionals can provide vision correction for 99.9% of spherical prescriptions,1 making it possible for patients who may have previously thought they couldn’t wear contact lenses.
“Through CooperVision’s innovation in contact lens design and manufacturing, practitioners have been able to fit virtually all their patients in the most prescribed family of monthly replacement contact lens on the market,”1,2 said Doug Brayer, Director of Marketing, Frequent Replacement Brands, Americas, CooperVision. “Now, we can deliver the extended range prescriptions at the same price and with the same rebate support as the standard range. This presents a significant opportunity for practices to bring spectacle wearers into Biofinity® lenses, increasing their volume of contact lens fits and growing their practice with new wearers.”
CooperVision Biofinity® and Biofinity® XR contact lenses feature Aquaform® Technology, an innovative material technology that hydrates contact lenses to twice their weight in water for natural wettability and incredible comfort.3
# # #
1. CVI data on file, 2020. Rx coverage database; 14 to 70 years; Rx with <0.75DC.
2. CVI data on file, 2021. US industry reports and internal estimates.
3. CVI data on file, 2022.
CooperVision, a division of CooperCompanies (Nasdaq:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women’s health company dedicated to assisting women, babies and families at the healthcare moments that matter most. Headquartered in San Ramon, Calif., CooperCompanies has a workforce of more than 15,000 with products sold in over 130 countries. For more information, please visit www.coopercos.com
Laura DiCaprio, Senior Counselor
McDougall Communications for CooperVision
Laura@mcdougallpr.com or +1-585-773-8005